Plante Moran Financial Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $70K | Sell |
317
-35
| -10% | -$9.68K | ﹤0.01% | 299 |
|
|
2026
Q1 | $104K | Buy |
352
+36
| +11% | +$10.7K | 0.01% | 222 |
|
|
2025
Q4 | $86.3K | Sell |
316
-3
| -0.9% | -$815 | 0.01% | 253 |
|
|
2025
Q3 | $86.2K | Buy |
319
+3
| +0.9% | +$816 | 0.01% | 266 |
|
|
2025
Q2 | $87.1K | Buy |
316
+38
| +14% | +$10.3K | 0.01% | 260 |
|
|
2025
Q1 | $73.8K | Sell |
278
-1,279
| -82% | -$315K | 0.01% | 285 |
|
|
2024
Q4 | $362K | Buy |
1,557
+53
| +4% | +$12.2K | 0.03% | 108 |
|
|
2024
Q3 | $332K | Buy |
1,504
+29
| +2% | +$6K | 0.03% | 123 |
|
|
2024
Q2 | $290K | Buy |
1,475
+1,250
| +556% | +$258K | 0.03% | 128 |
|
|
2024
Q1 | $48.4K | Buy |
+225
| New | +$47.3K | 0.01% | 344 |
|
|
2023
Q4 | – | Sell |
-25
| Closed | -$5.01K | – | 826 |
|
|
2023
Q3 | $5.01K | Buy |
+25
| New | +$4.97K | ﹤0.01% | 605 |
|
|
2023
Q1 | – | Sell |
-280
| Closed | -$47.1K | – | 808 |
|
|
2022
Q4 | $47.1K | Hold |
280
| – | – | 0.01% | 314 |
|
|
2022
Q3 | $50K | Sell |
280
-38
| -12% | -$7.51K | 0.01% | 305 |
|
|
2022
Q2 | $65K | Buy |
318
+8
| +3% | +$1.7K | 0.01% | 281 |
|
|
2022
Q1 | $74K | Sell |
310
-88
| -22% | -$20.7K | 0.01% | 271 |
|
|
2021
Q4 | $91K | Buy |
398
+88
| +28% | +$19.4K | 0.01% | 267 |
|
|
2021
Q3 | $60K | Sell |
310
-45
| -13% | -$9.12K | 0.01% | 349 |
|
|
2021
Q2 | $76K | Buy |
355
+18
| +5% | +$3.8K | 0.02% | 290 |
|
|
2021
Q1 | $69K | Sell |
337
-38
| -10% | -$7.49K | 0.02% | 296 |
|
|
2020
Q4 | $68K | Sell |
375
-34
| -8% | -$5.78K | 0.02% | 296 |
|
|
2020
Q3 | $68K | Sell |
409
-7
| -2% | -$1.18K | 0.02% | 273 |
|
|
2020
Q2 | $68K | Sell |
416
-95
| -19% | -$17K | 0.03% | 252 |
|
|
2020
Q1 | $88K | Buy |
511
+158
| +45% | +$31.4K | 0.04% | 201 |
|
|
2019
Q4 | $71K | Buy |
353
+56
| +19% | +$11.5K | 0.02% | 268 |
|
|
2019
Q3 | $63K | Buy |
297
+17
| +6% | +$3.55K | 0.02% | 305 |
|
|
2019
Q2 | $54K | Hold |
280
| – | – | 0.02% | 322 |
|
|
2019
Q1 | $46K | Hold |
280
| – | – | 0.01% | 353 |
|
|
2018
Q4 | $53K | Sell |
280
-22
| -7% | -$4.06K | 0.02% | 275 |
|
|
2018
Q3 | $51K | Buy |
302
+22
| +8% | +$3.7K | 0.02% | 284 |
|
|
2018
Q2 | $46K | Sell |
280
-181
| -39% | -$29.6K | 0.02% | 340 |
|
|
2018
Q1 | $75K | Sell |
461
-83
| -15% | -$13.2K | 0.04% | 272 |
|
|
2017
Q4 | $79K | Sell |
544
-7
| -1% | -$997 | 0.04% | 262 |
|
|
2017
Q3 | $75K | Hold |
551
| – | – | 0.04% | 245 |
|
|
2017
Q2 | $69K | Buy |
551
+5
| +0.9% | +$598 | 0.04% | 258 |
|
|
2017
Q1 | $65K | Buy |
546
+162
| +42% | +$19.5K | 0.04% | 271 |
|
|
2016
Q4 | $44K | Buy |
+384
| New | +$42.7K | 0.03% | 356 |
|
|
2016
Q3 | – | Sell |
-27
| Closed | -$3K | – | 942 |
|
|
2016
Q2 | $3K | Sell |
27
-86
| -76% | -$8.13K | ﹤0.01% | 711 |
|
|
2016
Q1 | $11K | Buy |
+113
| New | +$10.3K | 0.01% | 468 |
|
Other funds holding CME
AI
PAM
Plante Moran Financial Advisors's CME Position: Q2 2026 in Review
Plante Moran Financial Advisors reduced its CME Group (CME) stake by 9.9% in Q2 2026, selling an estimated $9.68K and leaving 317 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #299.
Plante Moran Financial Advisors first reported a position in CME in Q1 2016 and has held it in 38 quarters since. The position peaked at $362K in Q4 2024. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Plante Moran Financial Advisors held 317 shares of CME Group worth $70K as of Q2 2026.
- Plante Moran Financial Advisors sold 35 CME Group shares in Q2 2026, an estimated $9.68K.
- CME Group made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #299 holding.
- Plante Moran Financial Advisors first reported a position in CME Group in Q1 2016 and has held it in 38 quarters since.
- Plante Moran Financial Advisors's CME Group position peaked at $362K in Q4 2024.
- 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.